Hjem › Steatotisk leversykdom › Texas › Houston
Kliniske studier for Steatotisk leversykdom i Houston, TX
13 studier for Steatotisk leversykdom søker deltakere på steder i og rundt Houston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RekruttererFase 3
- 89bio Clinical Study Site, Houston
- 89bio Clinical Study Site, Houston
- 89bio Clinical Study Site, Houston
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RekruttererFase 3
- 89bio Clinical Study Site, Houston
- 89bio Clinical Study Site, Houston
- 89bio Clinical Study Site, Houston
- og 1 flere
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
RekruttererFase 3
- GSK Investigational Site, Houston
- GSK Investigational Site, Bellaire · 7 mi unna
- GSK Investigational Site, Humble · 17 mi unna
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
RekruttererFase 3
- GSK Investigational Site, Bellaire · 7 mi unna
- GSK Investigational Site, Humble · 17 mi unna
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
RekruttererFase 2
- Pioneer Research Solutions, Inc., Houston
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
RekruttererFase 3
- HRI- Medical Center, Houston
- Care Access - Houston, Houston
- Houston Research Institute, Houston
- og 3 flere
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
RekruttererFase 3
- Akero Clinical Study Site, Houston
- Akero Clinical Study Site, Houston
- Akero Clinical Study Site, Houston
- og 3 flere
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
RekruttererFase 2
- Houston Research Institute - Medical Center, Houston
- Houston Research Institute, Houston
- Bellaire Clinical Research, Bellaire · 7 mi unna
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
RekruttererFase 3
- GSK Investigational Site, Houston
- GSK Investigational Site, Bellaire · 7 mi unna
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
RekruttererFase 2
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
RekruttererFase 1/2Frivillige helsepersonell ønskes velkommen
- Pioneer Research Solutions, Houston
NAFLD Clinical Care Pathway
RekruttererFrivillige helsepersonell ønskes velkommen
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Evaluation of Non-Invasive Tests for Metabolic Liver Disease
RekruttererObservasjonsstudie
- First Surgical Hospital, Bellaire · 7 mi unna
Steatotisk leversykdom-studier i andre byer
- San Antonio, TX17 studier
- New York City, NY16 studier
- Miami, FL16 studier
- San Diego, CA14 studier
- Austin, TX13 studier
- Richmond, VA12 studier
- Tucson, AZ10 studier
- Chandler, AZ10 studier
- Hialeah, FL9 studier
- Dallas, TX9 studier
- Orlando, FL9 studier
- St. Louis, MO9 studier
Andre studier i Houston
- Ikke-småcellet lungekreft145 studier
- Brystkreft126 studier
- Kreft (alle typer)121 studier
- Metastatisk kreft104 studier
- Kolorektal kreft102 studier
- Eggstokkreft89 studier
- Akut myelogen leukemi85 studier
- Lungekreft78 studier
- Prostatakreft76 studier
- Endometriekreft68 studier
- Pankreaskreft61 studier
- Melanom59 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.